ClinicalTrialsFinder

Advanced KRAS G12D Mutant Solid Tumors Clinical Trials in Chengdu, Sichuan

1 recruitingChengdu, Sichuan, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations

Advanced KRAS G12D Mutant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.153 enrolled2 locationsNCT07134998